An identification and functional evaluation of a novel CYP2C9 variant CYP2C962
Warfarin is the most commonly used anticoagulant in the clinical treatment of thromboembolic diseases. The dose of warfarin varies significantly within populations, and the dose is closely related to the genetic polymorphisms of the CYP2C9 and VKORC1 genes. In this study, a new CYP2C9 nonsynonymous...
Saved in:
Published in | Chemico-biological interactions Vol. 327; p. 109168 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
25.08.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!